User talk:Z3332250: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
**Coenzyme Q10 and Vitamin E | **Coenzyme Q10 and Vitamin E | ||
Antioxidants treatment of FA which have shown most promise is Idebenone and Coenzyme Q10 with Vitamin E. Antioxidants have shown degree of reduction on oxidative stress in mitochondria though are still going through clinical trials. | Antioxidants treatment of FA which have shown most promise is Idebenone and Coenzyme Q10 with Vitamin E. Antioxidants have shown degree of reduction on oxidative stress in mitochondria though are still going through clinical trials<ref name="PMID:19283349">19283349</pubmed></ref>.Conenzyme Q10 an electron carrier with a reduction of oxidative stress effect from the combination of vitamin E, combination of Q10 and vitamin E displayed a positive effect<ref name="PMID:19049556"><pubmed>19049556</pubmed></ref>. Where Q10 and vitamin E conveyed the cardiac and skeletal improvement with the betterment of the mitochondrial synthesis<ref name="PMID:15824263"><pubmed>15824263</pubmed></ref>. | ||
Idebnone operates with a duel function where reversing redox reactions affecting electron balance in the mitochondria while also supporting mitochondria functions preventing damage<ref name="PMID:19283347"><pubmed>19283347</pubmed></ref>. | |||
Revision as of 22:42, 7 September 2011
Articles to read:
"""Carido"""
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728941/?tool=pmcentrez
- http://www.ncbi.nlm.nih.gov/pubmed/2940284
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728941/pdf/v081p00141.pdf
- http://www.ncbi.nlm.nih.gov/pubmed/2944367
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1894724/?tool=pmcentrez
[1]
Treatment
friedreich Ataxia (FA) a progressive neurological congenital disorder[2], wtih no treatment identified only possible pharmaceutics which can reduce the progression of FA however not significantly. Whereas significant treatment poties of FA or reduction in progression are the following:
- Iron-chelation
- deferoxamine
- Antioxidants:
- Idebenone
- Coenzyme Q10 and Vitamin E
Antioxidants treatment of FA which have shown most promise is Idebenone and Coenzyme Q10 with Vitamin E. Antioxidants have shown degree of reduction on oxidative stress in mitochondria though are still going through clinical trials[3].Conenzyme Q10 an electron carrier with a reduction of oxidative stress effect from the combination of vitamin E, combination of Q10 and vitamin E displayed a positive effect[4]. Where Q10 and vitamin E conveyed the cardiac and skeletal improvement with the betterment of the mitochondrial synthesis[5].
Idebnone operates with a duel function where reversing redox reactions affecting electron balance in the mitochondria while also supporting mitochondria functions preventing damage[6].
